Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

83rd Congress of the European Atherosclerosis Society

22-25 March 2015, Glasgow, UK

FH – the challenges for the next 10 years?

FH – the challenges for the next 10 years?

Kees Hovingh, Academic Medical Center, Amsterdam, the Netherlands In a session on familial hypercholesterolaemia (FH, inherited high cholesterol) at the 83rd Annual Congress of the European Atherosclerosis Society (EAS), Dr Kees Hovingh outlined what he saw as the challenges for FH in the next decade….

read more »
EAS 2015: Climbing stairs at work lowers PCSK9

EAS 2015: Climbing stairs at work lowers PCSK9

Regular physical activity is recommended as one of the key lifestyle strategies underpinning cardiovascular disease prevention. Much of the benefit has been ascribed to lowering of triglycerides and raising high-density lipoprotein (HDL) cholesterol. While studies vary, there is also some evidence to suggest benefit of…

read more »
EAS 2015: PCSK9 inhibitors effective with high-intensity statins

EAS 2015: PCSK9 inhibitors effective with high-intensity statins

High-intensity statins are indicated in patients with or at high risk of cardiovascular disease. However, even with maximally tolerated doses, the majority fail to achieve guideline-recommended low-density lipoprotein (LDL) cholesterol goal. Recent data from EUROASPIRE IV, a survey of secondary prevention care across Europe, show…

read more »
PlayEuropean Atherosclerosis Society Consensus Panel on statin-associated muscle symptoms: Professor Erik Stroes, Academic Medical Center, the Netherlands

European Atherosclerosis Society Consensus Panel on statin-associated muscle symptoms: Professor Erik Stroes, Academic Medical Center, the Netherlands

PCSK9 Forum caught up with Professor Stroes at the 83rd Congress of the European Atherosclerosis Society (EAS), Glasgow 22-25 March, 2015 to discuss this recent EAS Consensus Panel paper. Statin-associated muscle symptoms (SAMS) were very much the hot topic at EAS Glasgow, reflecting the high…

read more »
Statins and muscle symptoms: New EAS Consensus Panel statement

Statins and muscle symptoms: New EAS Consensus Panel statement

The European Atherosclerosis Society (EAS) Consensus Panel has published new guidance on the diagnosis, assessment and treatment of statin-associated muscle symptoms (SAMS). Unique to this statement is an overview of current understanding of the pathophysiology of statin myopathy. Without doubt, statins are the therapeutic cornerstone…

read more »